Related Experiment Video

Updated: Jun 27, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Genetic Testing in Gastrointestinal Polyposis Syndromes: Considerations in Pediatrics

Suzanne P MacFarland1,2, Kristin Zelley1, Isabel Rojas3

  • 1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Genes
|June 26, 2026
PubMed

Insights

Pediatric gastrointestinal polyps signal hereditary syndromes, increasing early cancer risk. Genetic testing is crucial for diagnosis, management, and family screening, guiding clinical steps and surveillance.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Genetics
  • Cancer Predisposition Syndromes

Background:

  • Pediatric gastrointestinal polyps often indicate underlying hereditary syndromes.
  • These syndromes are linked to multisystem issues and heightened early-onset cancer risk.
  • Early identification is vital for timely intervention and management.

Purpose of the Study:

  • To propose a stepwise genetic testing approach for children with gastrointestinal polyps.
  • To guide clinicians in characterizing hereditary syndromes and informing management.
  • To facilitate cascade testing for affected family members.

Main Methods:

  • Review of current literature on pediatric polyposis syndromes.
  • Analysis of genetic testing strategies in pediatric populations.
  • Development of a tiered testing protocol based on clinical presentation.

Main Results:

  • Genetic testing confirms hereditary syndromes in a significant proportion of pediatric polyp cases.
  • Syndrome characterization guides specific surveillance and management plans.
  • Cascade testing identifies at-risk relatives, enabling early detection.

Conclusions:

  • Genetic testing is essential for pediatric gastrointestinal polyps to identify hereditary cancer syndromes.
  • A structured, stepwise approach optimizes genetic testing in children.
  • This strategy improves patient care and facilitates family-wide risk assessment.

Keywords:
PTEN hamartoma tumor syndromePeutz-Jeghers syndromefamilial adenomatous polyposisjuvenile polyposis syndromepolyposis syndromes

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...